May 2020 – Policy & Medicine

CMS Releases Latest Outlook for Future Drug Spending

FDA User-Fee Reviews Continue through COVID-19

Consumers’ Impression of Pharma Is More Favorable Now

California Risperdal Suits to be Renewed?

FDA CDRH Issues Guidance on Notifications of Medical Device Shortages

HHS Quietly Outlaws Surprise Medical Billing for Everyone?

HHS Issues Blanket Waivers for Stark Law – Physician Self-Referral in Response to Pandemic

Decrease in Routine Medical Care for Hospitals Leads to Furloughs and Pay Cuts

CMS Add COVID-19 Clinical Trial Participation Improvement Activity to MIPS Quality Payment Program

FDA Issues Revised Guidance on Adverse Event Reporting During a Pandemic